AbstractDoxorubicin (DOX) has not only chronic, but also acute toxic effects in the heart, ascribed to the generation of reactive oxygen species (ROS). Focusing on the DOX-induced early biochemical changes in rat cardiomyocytes, we demonstrated that lipid peroxidation is an early event, in fact conjugated diene production increased after 1-h DOX exposure, while cell damage, evaluated as lactate dehydrogenase (LDH) release, was observed only later, when at least one third of the cell antioxidant defences were consumed. Cell pre-treatment with α-tocopherol (TC) inhibited both conjugated diene production and LDH release. In cardiomyocytes, DOX treatment caused a maximal increase in glucose uptake at 1 h, demonstrating that glucose transport ma...
The anthracycline-mediated cardiotoxicity is still not completely understood. To examine the impact ...
AbstractGeneration of reactive oxygen species and mitochondrial dysfunction has been implicated in d...
Although doxorubicin (DOX) is a very effective antineoplastic agent, its clinical use is limited by ...
AbstractDoxorubicin (DOX) has not only chronic, but also acute toxic effects in the heart, ascribed ...
Doxorubicin (DOX) has not only chronic, but also acute toxic effects in the heart, ascribed to the g...
AbstractDoxorubicin (DOX)-induced cardiotoxicity is thought to be caused by free radical-mediated me...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
Systemic chemotherapy is the primary treatment for much diffuse solid neoplasms or hematological mal...
Doxorubicin (DXR), an anticancer drug, is limited in its use due to severe cardiotoxic effects. Thes...
The cardiac toxicity of doxorubicin (DOX), a potent anticancer anthracycline antibiotic, is believed...
The implication of oxidative stress as primary mechanism inducing doxorubicin (DOX) cardiotoxicity i...
Doxorubicin is a very effective chemotherapeutic agent. However, its use is limited by serious cardi...
Heart failure (HF) is increasingly recognized as the major complication of chemotherapy regimens. De...
AbstractDoxorubicin (DOX)-induced cardiotoxicity is thought to be mediated by the generation of supe...
Doxorubicin (DOX) is a potent chemotherapeutic with distinct cardiotoxic properties. Understanding t...
The anthracycline-mediated cardiotoxicity is still not completely understood. To examine the impact ...
AbstractGeneration of reactive oxygen species and mitochondrial dysfunction has been implicated in d...
Although doxorubicin (DOX) is a very effective antineoplastic agent, its clinical use is limited by ...
AbstractDoxorubicin (DOX) has not only chronic, but also acute toxic effects in the heart, ascribed ...
Doxorubicin (DOX) has not only chronic, but also acute toxic effects in the heart, ascribed to the g...
AbstractDoxorubicin (DOX)-induced cardiotoxicity is thought to be caused by free radical-mediated me...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
Systemic chemotherapy is the primary treatment for much diffuse solid neoplasms or hematological mal...
Doxorubicin (DXR), an anticancer drug, is limited in its use due to severe cardiotoxic effects. Thes...
The cardiac toxicity of doxorubicin (DOX), a potent anticancer anthracycline antibiotic, is believed...
The implication of oxidative stress as primary mechanism inducing doxorubicin (DOX) cardiotoxicity i...
Doxorubicin is a very effective chemotherapeutic agent. However, its use is limited by serious cardi...
Heart failure (HF) is increasingly recognized as the major complication of chemotherapy regimens. De...
AbstractDoxorubicin (DOX)-induced cardiotoxicity is thought to be mediated by the generation of supe...
Doxorubicin (DOX) is a potent chemotherapeutic with distinct cardiotoxic properties. Understanding t...
The anthracycline-mediated cardiotoxicity is still not completely understood. To examine the impact ...
AbstractGeneration of reactive oxygen species and mitochondrial dysfunction has been implicated in d...
Although doxorubicin (DOX) is a very effective antineoplastic agent, its clinical use is limited by ...